MetaVia Inc. Share Price
NASDAQ: MTVA | Micro CapMetaVia Inc. Stock Performance
MetaVia Inc. Share Price Today
As of 29 October 2026, MetaVia Inc.'s share price is $1.18. The stock opened at $1.17, compared to its previous close of $1.15. During today's trading session, MetaVia Inc.'s share price traded between $1.17 and $1.17, with an average price of $1.17. Over the past 52 weeks, the stock has recorded a high of $12.68 and a low of $0.57. In terms of performance, MetaVia Inc.'s share price has declined by 18.90% over the last six months and is up 20.41% on a year-on-year basis.
MetaVia Inc. Share Price Chart
MetaVia Inc. Quarterly Profit & Loss
All figures in USD
MetaVia Inc. Annual Profit & Loss
All figures in USD
About MetaVia Inc.
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. Vanoglipel (DA-1241) is a novel GPR119 (GPR119) agonist with development optionality as a standalone or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). Agonism of GPR119 in the gut promotes the release of key gut peptides, glucagon-like peptide-1 (GLP-1), glucagon-dependent insulinotropic polypeptide receptor (GIP), and peptide YY.
MetaVia Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.54 | $1.17 | -25.80% |
Sep 2026 | $1.68 | $1.57 | -7.10% |
Aug 2026 | $1.51 | $1.69 | +19.01% |
Jul 2026 | $1.43 | $1.42 | -0.35% |
Jun 2026 | $2.76 | $1.43 | -49.38% |
May 2026 | $1.46 | $2.81 | +93.47% |
Apr 2026 | $1.23 | $1.46 | +21.25% |
Mar 2026 | $1.53 | $1.20 | -20.53% |
Feb 2026 | $2.53 | $1.51 | -37.86% |
Jan 2026 | $8.55 | $2.43 | -71.45% |
Dec 2025 | $0.77 | $8.51 | +970.44% |
Nov 2025 | $1.07 | $0.80 | -18.88% |